We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+13.06%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$8.1B
AUM Growth
+$4.9B
Cap. Flow
+$4.22B
Cap. Flow %
52.11%
Top 10 Hldgs %
26.76%
Holding
6,444
New
505
Increased
3,426
Reduced
1,637
Closed
524

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$314M
2
AAPL icon
Apple
AAPL
+$247M
3
MSFT icon
Microsoft
MSFT
+$235M
4
AMZN icon
Amazon
AMZN
+$110M
5
NVDA icon
NVIDIA
NVDA
+$99M

Sector Composition

Rank Sector Weight
1 Technology 26.14%
2 Financials 11.29%
3 Healthcare 10.69%
4 Consumer Discretionary 10.28%
5 Industrials 7.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CPZ
5951
Calamos Long/Short Equity & Dynamic Income Trust
CPZ
$268M
-167
Closed -$2.47K
CRD.B icon
5952
Crawford & Co Class B
CRD.B
$604M
-1,547
Closed -$13.3K
CRDF icon
5953
Cardiff Oncology
CRDF
$77.2M
-360
Closed -$500
CSBR icon
5954
Champions Oncology
CSBR
$72.1M
-21
Closed -$130
CSPI icon
5955
CSP Inc
CSPI
$82.1M
-672
Closed -$5.88K
CSQ icon
5956
Calamos Strategic Total Return Fund
CSQ
$3.35B
-45
Closed -$633
CSTE icon
5957
Caesarstone
CSTE
$79.5M
-3,149
Closed -$13.5K
CWI icon
5958
State Street SPDR MSCI ACWI ex-US ETF
CWI
$2.85B
-119
Closed -$2.96K
DAC icon
5959
Danaos Corp
DAC
$2.56B
-1,012
Closed -$67K
DAVA icon
5960
Endava
DAVA
$156M
-2,089
Closed -$120K
DBEU icon
5961
Xtrackers MSCI Europe Hedged Equity ETF
DBEU
$799M
-104
Closed -$3.69K
DDI
5962
DoubleDown Interactive
DDI
$588M
-263
Closed -$2.23K
DERM icon
5963
Journey Medical
DERM
$177M
-1,730
Closed -$4.74K
DFAT icon
5964
Dimensional US Targeted Value ETF
DFAT
$14.7B
-4,485
Closed -$205K
DFIC icon
5965
Dimensional International Core Equity 2 ETF
DFIC
$15.3B
-43
Closed -$1K
DFIV icon
5966
Dimensional International Value ETF
DFIV
$21.7B
-1,249
Closed -$40.7K
DFSV
5967
Dimensional US Small Cap Value ETF
DFSV
$8.36B
-26,392
Closed -$669K
DFUS
5968
Dimensional US Equity ETF
DFUS
$21.6B
-938
Closed -$43.7K
DIVB icon
5969
iShares Core Dividend ETF
DIVB
$1.77B
-15,451
Closed -$575K
DQ
5970
Daqo New Energy
DQ
$996M
-6,443
Closed -$195K
DTCK
5971
DELISTED
Davis Commodities
DTCK
-60
Closed -$3.52K
DTIL icon
5972
Precision BioSciences
DTIL
$207M
-969
Closed -$9.91K
EARN
5973
Ellington Residential Mortgage REIT
EARN
$165M
-1,318
Closed -$8.19K
ECDA
5974
DELISTED
ECD Automotive Design
ECDA
-1
Closed -$1.46K
EDD
5975
Morgan Stanley Emerging Markets Domestic Debt Fund
EDD
$385M
-3,000
Closed -$12.8K

Similar funds

Tower Research Capital (TRC)'s Q4 2023 Portfolio in Review

As of Q4 2023, Tower Research Capital (TRC) held 6,444 positions worth $8.1B, up 153% from $3.2B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) deployed $4.22B of net new capital in Q4 2023, opening 505 new positions and adding to 3,426 existing holdings. Its largest new stake was Veralto: 28,523 shares worth $2.35M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares MSCI EAFE ETF, an estimated $21.7M trimmed.

  • Tower Research Capital (TRC)'s largest Q4 2023 buy was Veralto: 28,523 shares worth $2.35M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $314M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2023 reduction was iShares MSCI EAFE ETF, cutting an estimated $21.7M.
  • Tower Research Capital (TRC) fully exited Vanguard Morningstar Total Stock Market ETF in Q4 2023, selling an estimated $6.02M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $8.1B portfolio in Q4 2023.
  • Tower Research Capital (TRC) opened 505 new positions and closed 524 in Q4 2023.
  • Tower Research Capital (TRC)'s portfolio value rose 153% quarter-over-quarter to $8.1B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2023, filed 13 Feb 2024.